Fig. 1From: A validated analysis pipeline for mass spectrometry-based vitreous proteomics: new insights into proliferative diabetic retinopathyExperiment 1 design. A single 10-plex (1.1) containing individual control samples and pool 1 aliquots was subjected to TMT-MS. The 5 individual control samples served as biological replicates, while the pool 1 aliquots (1.1–1.5) served as technical replicatesBack to article page